TOKYO and CAMBRIDGE, Mass., Dec 4, 2025 - (JCN Newswire via SeaPRwire.com) -  Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that the latest findings on time savings with continued treatment with humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody lecanemab (generic name, U.S. brand name LEQEMBI®)  were presented at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference. Additionally, a scientific symposium was held on the subcutaneous formulation (SC-AI), which was approved for maintenance treatment in the United States in August 2025, and the rolling supplemental Biologics License Application (sBLA) for initiation treatment was completed in November 2025. The application for a subcutaneous injectable formulation in Japan was submitted in November 2025.Alzheimer's disease (AD) is a progressive, relentless disease with Aβ and tau as hallmarks, that is caused by a continuous underlying neurotoxic process driven by protofibrils* (PF) that begins before amyloid plaque removal ...

HONG KONG, December 3, 2025 - (ACN Newswire via SeaPRwire.com) – The 26th Hong Kong Forum, jointly organised by the Hong Kong Trade Development Council (HKTDC) and the Federation of Hong Kong Business Associations Worldwide, wrapped up after the successful two-day event attracted more than 320 representatives from Hong Kong business associations worldwide and business leaders from 33 countries and regions.This year’s Hong Kong Forum focused on how enterprises can leverage Hong Kong’s distinctive advantages of enjoying strong support from the Chinese Mainland and being closely connected to the world as an ideal springboard for expanding abroad. Also covered was how Hong Kong attracts talent and infuses innovative thinking across industries, driving transformation while creating more development opportunities. The programme featured keynote speeches, a series of networking activities, and local visits to give participants deeper insights into Hong Kong from multiple perspectives.Helping mainland enterprises “go global” and tap into international marketsIn her welcome remarks, Margaret Wong, Chairperson of the Federation of Hong Kong Busine...

TOKYO, Dec 3, 2025 - (JCN Newswire via SeaPRwire.com) - Anime Tokyo Station is an anime exhibition site focused on Japanese anime content, which has developed a devout fan base around the world. From November 15, 2025 to February 15, 2026, it will be holding the “Digimon Adventure 02” & “Magical DoReMi #” ANIME 25TH ANNIVERSARY JOINT EXHIBITION. A sneak preview was held for the press on November 14, the day before the exhibition opened.Visitors to the anniversary joint exhibition can enjoy a variety of unique displays at Anime Tokyo Station, including rare character design materials, interactive digital content, and photo spots.Please visit Anime Tokyo Station and experience the full appeal of Digimon Adventure 02 and Magical DoReMi #.Exhibits ”Digimon Adventure 02” ＆ “Magical DoReMi #” ANIME 25TH ANNIVERSARY JOINT EXHIBITIONWhat is “Digimon Adventure 02”?Digimon Adventure 02 is the second series in the franchise, serving as a sequel to Digimon Adventure, which depicted the growth and adventures of children and their Digimon partners in the Digital World.Set three years after Taichi and friends’ ...

TOKYO, Dec 2, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito) today announced that new data on anti-tau antibody etalanetug (development code: E2814) was presented at the 18th Clinical Trials on Alzheimer’s Disease Conference (CTAD). Etalanetug is designed to bind to the microtubule-binding region (MTBR) of tau protein and prevent the seeding and propagation of tau pathology.Anti-tau therapeutic antibody, etalanetug, reduces the novel biomarker plasma eMTBR-tau243 in patients with DIAD (Presentation: December 1, 4:35 PM PT)This presentation is based on the Phase Ib/II study (E2814-103) conducted in individuals (n=7) with dominantly inherited Alzheimer’s disease (DIAD)*. In this study, as previously reported, tau aggregates in the brains of individuals (n=3) were measured using tau PET, and the results showed that the observed tau PET signals were stabilized or trended toward decrease following administration of etalanetug, suggesting that etalanetug inhibited tau propagation and suppressed or reduced the accumulation of tau aggregates in brains.1The study evaluated eMTBR-tau243 as a specific biomarker of tau pathology pr...

TOKYO, Dec 2, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) will begin offering its "NEC AI Agent Service for Procurement Negotiations" in Japan starting this December. This service utilizes NEC's proprietary AI technology, "Automated Negotiation AI," to autonomously generate optimal transaction terms for procurement operations in the manufacturing industry and to negotiate with suppliers.This service automates complex delivery date and quantity adjustment negotiations in manufacturing, drastically reducing the time spent on transaction negotiations. It enables rapid response to demand fluctuations and significantly improves operational efficiency.NEC conducted a proof-of-concept (POC) at an NEC Group company in November 2024, successfully automating delivery date and quantity adjustments with suppliers for the procurement of approximately 1,300 parts.In this proof-of-concept, the "automated agreement rate"—the percentage of agreements reached solely by AI without procurement personnel intervention—reached 95%. Negotiations concluded under optimal conditions for both the supplier and NEC. This confirmed that the adjustment time from neg...

KAWASAKI, Japan, Dec 2, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced the development of a new technology to make collaboration between robots and humans easier, safer and more efficient. The spatial world model technology makes it possible for AI to predict the future behaviors and states of different actors and objects within a space, and facilitates smooth collaboration between humans and robots, as well as optimal coordination among robots. This new development comes as part of Fujitsu’s broader research and development efforts in the field of physical AI.The spatial world model technology will be showcased at CES2026, held in Las Vegas from January 6 to January 9, 2026. Fujitsu also plans to conduct technical demonstrations at its headquarters during fiscal year 2026.Spatial World Model Technology Features1. Construction of a spatial world model using 3D scene graphs focusing on human, robot, and object interactionsIn physical environments, the spatial situation changes dynamically as actors within the space (i.e., people, robots, etc.) move and act. While technologies that use capturing data from cameras to understand these spatial dynamics have been...

KAWASAKI, Japan, Dec 2, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced the establishment of Frontria, an international consortium bringing together over 50 global organizations to collaboratively address the escalating challenges of AI-generated disinformation, misinformation, AI system vulnerabilities, and regulatory compliance. This initiative aims to foster a healthy and resilient digital society by pooling cutting-edge technologies and expertise to enhance information reliability and ensure AI trustworthiness and security.   Frontria will serve as a dynamic platform for participating organizations to share their technological capabilities, identify challenges, articulate needs, and collectively drive risk mitigation and transformative solutions from a global perspective.Frontria aims to rapidly create concrete applications and services, and by quickly sharing information about their use cases, it will seek to promote the adoption of technological IP that enhances the reliability and safety of AI technology and counters misinformation. In fiscal year 2025, the consortium will commence activities with participating organizations from Japan, Eu...

KAWASAKI, Japan, Dec 1, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced the successful development of a technology for molecular dynamics (MD) simulation that enables atomic-level structural analysis of the solid electrolyte interphase (SEI) [1] formation process in all-solid-state batteries. This process, previously difficult to analyze, significantly impacts battery performance. Fujitsu achieved this breakthrough by developing a neural network potential (NNP) [2] training method using knowledge distillation [3], enabling stable, long-duration MD simulations. The newly developed technology can now rapidly and accurately reproduce the behavior of all-solid-state battery electrolyte membrane and electrode interface structures [4] with over 100,000 atoms for 10 nanoseconds, requiring only one week of computation.  The innovative nature of this technology has been recognized with the Electric Science and Technology Promotion Award for 2025 from The Promotion Foundation of Electrical Science and Engineering, which was awarded on November 25, 2025.By linking these technologies, Fujitsu aims to establish a new materials development workflow that accelerates materia...

KAWASAKI, Japan, Dec 1, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced the development of a multi-AI agent collaboration technology that enables secure collaboration and swift response to changing circumstances among AI agents from different companies and vendors within a supply chain. Leveraging this technology, Fujitsu will start field trials in January 2026 to optimize the supply chain of Rohto Pharmaceutical Co., Ltd. in collaboration with the Institute of Science Tokyo (Science Tokyo). This innovation not only streamlines daily supply chain operations but also facilitates rapid recovery during emergencies like sudden demand shifts or disasters.In addition, Fujitsu will contribute to the new industry promotion activities of the Council on Competitiveness-Nippon (COCN) to realize AI spaces that enable secure data and AI collaboration across different companies, aiming to strengthen the competitiveness of Japanese industry through agentic AI.Fujitsu will continue to advance demonstration and technological enhancement with Science Tokyo and Rohto Pharmaceutical, aiming for expansion into diverse industries, including manufacturing. Fujitsu will also...

KAWASAKI, Japan, Dec 1, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced the launch of "Fujitsu Accelerator Program for SPORTS," a global partner co-creation program aimed at fostering new innovation in the sports sector.Through Fujitsu Accelerator, Fujitsu collaborates with startups and other companies to create new businesses and solve challenges by leveraging cutting-edge technologies such as AI and quantum computing. This new program seeks to expand the value and monetization potential of corporate sports. It will achieve this by combining the strengths of Fujitsu's sports teams and athletes—including its American football, women's basketball, and track and field teams—and facilities, with the innovative technologies and ideas of partner companies. Through co-creation, the program aims to generate new value in sports and related fields such as entertainment, tourism, and merchandise and build a corporate sports ecosystem.Fujitsu will begin recruiting new partners who want to engage in new business creation from December 1. Selected companies will be determined after a pitch event scheduled for February 2026. Proof of Concept (PoC) initiatives a...

TOKYO and CAMBRIDGE, Mass., Nov. 28, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has filed a new drug application for “LEQEMBI(R)” (brand name, generic name: lecanemab) seeking approval for a subcutaneous formulation (subcutaneous autoinjector: SC-AI) as a new route of administration to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA).The application is based on data from multiple subcutaneous (SC) administration sub-studies of lecanemab conducted as part of the Phase 3 Clarity AD open-label extension (OLE), following the 18-month core study in individuals with Mild Cognitive Impairment (MCI) due to Alzheimer‘s disease (AD) or mild stage of AD dementia (collectively referred to as early AD). It was confirmed that the once weekly administration of SC-AI 500mg resulted in equivalent exposure to once every two weeks intravenous (IV) administration and similar clinical and biomarker benefits. Subcutaneous administration ...

TOKYO, Nov 28, 2025 - (JCN Newswire via SeaPRwire.com) - The Japanese Foundation for Cancer Research (JFCR), NEC Corporation (NEC), and Taiho Pharmaceutical Co., Ltd. (Taiho) have signed a three-party joint research (Joint Research) agreement aimed at developing new cancer vaccines through the utilization of whole-genome information.This Joint Research project will be carried out as part of the Japan Agency for Medical Research and Development (AMED)’s "Action Plan for Whole-Genome Analysis for Cancer and Rare/Intractable Diseases," within the research initiative "Demonstration of the Clinical Utility of Cancer Whole-Genome Analysis and Research on Establishing Systems for Patient Benefit."JFCR, NEC, and Taiho will design and develop shared neoantigen cancer vaccines that target newly identified cancer-specific antigens (neoantigens) shared among multiple patients with cancer. The initiative aims to demonstrate the therapeutic efficacy of vaccines for a wide range of cancer patients and to be quickly available.The Joint Research will utilize the unique research information, AI-based drug discovery technologies, and experimental materials held by the three parties. Specif...

 TOKYO, Nov 28, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) published its integrated report, "MHI REPORT 2025", which provides a balance of financial and non-financial information of MHI Group and its "SUSTAINABILITY DATABOOK 2025" (the Databook), an annual report summarizing non-financial information of the Group."MHI REPORT 2025" provides explanations centering on our new corporate strategy, Innovative Total Optimization (ITO) established by CEO Eisaku Ito, who took the office in April. In a message from the President and CEO at the beginning, CEO Ito outlines his management approach to achieve Group-Wide Optimization and Reach Expansion to unlock growth potential and establish a virtuous cycle of high profitability and growth investments by creating new value. Next, in a message from the CFO, CFO Hiroshi Nishio shares his perspective on the financial strategy that supports medium- to long-term growth to meet the capital market's expectations of the Group, from perspectives such as financial discipline, resource allocation, and portfolio management.Two feature articles are included. The topic of the first feature is at the forefront of o...

Japan, Nov 28, 2025 - (JCN Newswire via SeaPRwire.com) - Sharp has been awarded the "Asia IP Elite 2025" selected by the internationally renowned intellectual property media, Intellectual Asset Management (IAM) for the second consecutive year.Award PlaqueThe Asia IP Elite is an award given by IAM to companies with an intellectual property department and are actively involved in intellectual property transactions and disputes, or that take an innovative approach to extracting value from intellectual property. A total of 101 companies (25 from Japan) have been selected in 2025.Sharp positions its intellectual property strategy as one of its important management strategies, pursuing it together with business and R&D strategies and actively obtaining intellectual property rights. Through such efforts, Sharp is working to enhance its business advantage and enforce its management foundation.To promote this initiative, sharp has been working with Sharp IP Infinity Co., Ltd. which handles intellectual property operations, to strategically create intellectual property value that is closely tied to the field, to create standard essential patents in technological fields such as communicat...

KAWASAKI, Japan, Nov 28, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced that it has built a platform for NSK Ltd. to support a business model that enables co-creation of value with user companies throughout the product lifecycle of bearing products. This system, which leverages Fujitsu Sustainability Value Accelerator, an offering provided through Fujitsu’s Uvance business model focused on addressing societal challenges, will collect and utilize bearing data across departments, processes, and companies throughout the entire product lifecycle, and provide services for condition monitoring and maintenance. The initiative will promote the reconditioning and reuse of bearing products, supporting NSK's corporate philosophy of contributing to a sustainable society through global environmental conservation, and enhance corporate value.The platform is planned for introduction to bearing product customers as a "Powered by Uvance" product. NSK is currently conducting verification with early adopters and will continuously enhance this system through these trials, aiming for full-scale operation of the platform from 2026. Fujitsu will support NSK in the deployment...

KAWASAKI, Japan, Nov 28, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced the launch of the Japan Edition of SAP Fioneer Cloud for Insurance, a next-generation platform designed to support core operations in the Japanese insurance industry. Developed in strategic partnership with SAP Fioneer GmbH, the new platform will be available in Japan starting at the end of November, 2025.Built upon SAP Fioneer's globally proven SAP Fioneer Cloud for Insurance [1], the new edition integrates Fujitsu's proprietary functionalities and services tailored to the specific regulatory requirements and business practices of the Japanese insurance market. These all-in-one platform covers a comprehensive range of core insurance operations and systems such as product, policy and claim management. Offered as part of Fujitsu's Uvance initiatives focused on the financial industry, which aim to accelerate digital transformation for financial institutions and contribute to solving societal challenges, the platform will support operational improvements for Japanese insurance companies and drive business transformation across the industry.The platform is enhanced with Fujitsu's unique deve...

TOKYO, Nov 27, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has developed a sales support solution that leverages Agentic AI to advance digital transformation (DX) for sales. Based on sales representatives' activity records, such as meeting minutes, and standard proposal templates, this solution automatically generates sales proposals and discussion sheets that address customer challenges all at once. The solution is expected to be available in Japan starting in late March 2026.Additionally, the solution leverages internally accumulated information assets to enable high-quality proposals that are not dependent on individual employee expertise. Moreover, it can integrate with existing sales support systems already in use within a company. This can significantly improve the operational efficiency of sales representatives without major changes to business workflows, enabling them to quickly deliver high-quality proposals to customers.NEC promotes the DX of sales using a wide range of resources and expertise, including AI, thereby contributing to the advancement and efficiency of sales operations.Solution OverviewIn recent years, the rapid evolution o...

Kawasaki and Yamaguchi, Japan, Nov 27, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited and Yamaguchi University today announced the successful development of a low-power edge computing technology that enables image processing on small satellites using redundant GPUs within 10 minutes (near real time). This innovative technology is designed for low-Earth orbit Synthetic Aperture Radar (SAR) satellites, which illuminate the Earth's surface with microwaves and receive reflected waves to create two-dimensional images.The new system offers high fault tolerance against cosmic radiation and operates efficiently within the typical 20W power constraints of small satellites. It can process data, including error detection and reprocessing, within approximately 10 minutes. Validated with raw SAR data on a satellite prototype, the technology successfully performed both L1 [1] (raw data to 2D image) and L2 [2] (image to observed quantity) processing, accurately determining ocean surface wind speeds. This versatile technology is also applicable to optical and multi-hyperspectral satellites.Fujitsu plans to release the developed programming environment, Fujitsu Research Soft Error R...

TOKYO, Nov 27, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Electric Building Solutions Corporation (MEBS, Head Office: Chiyoda-Ku, Tokyo; President: Iwao Oda) today announced that Mitsubishi Electric de Mexico S.A. de C.V. (MELMEX), which is responsible for elevator and escalator sales in Mexico, completed the renewal of one of the spiral escalators at the Liverpool department store in the Centro Santa Fe shopping mall in Santa Fe, Mexico on October 15. This project was the first-ever spiral escalator renewal project conducted anywhere in the world.Spiral escalator after the renewalSpiral escalators, which are curved escalators that trace an arc, are manufactured exclusively by MEBS. The unit that was renewed this time is one of two spiral escalators in Mexico delivered by the company in 1992 that remain in operation today. Elevators and escalators undergo continuous and appropriate maintenance in order to sustain and restore their functionality. However, the risks associated with deterioration through aging and the number of discontinued or unavailable parts increase over time. Through this renewal, the company replaced key components at an optimal timing, enhancing the e...

TOKYO and CAMBRIDGE, Mass., Nov. 26, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: HaruoNaito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has completed the rolling submission of the Supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: LEQEMBI®) subcutaneous autoinjector(SC-AI), LEQEMBI IQLIK, as a weekly starting dose after the FDA granted Fast Track Status. LEQEMBI is indicated for the treatment of Alzheimer’s disease (AD) in patients with Mild Cognitive Impairment(MCI) or mild dementia stage of disease (collectively referred to as early AD). Upon acceptance of the sBLA, the FDA will set a Prescription Drug User Fee Act (PDUFA) action date (target date for review completion). The sBLA is supported by data evaluating subcutaneous (SC) administration of lecanemab across arange of doses and as part of sub-studies within the Phase 3 Clarity AD open-label extension (OLE)following the 18-month core study in individua...